The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure
- 31 July 1996
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 28 (1) , 162-167
- https://doi.org/10.1016/0735-1097(96)00098-8
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition.Circulation, 1994
- Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.Circulation, 1994
- Intracoronary angiotensin-converting enzyme inhibition improves diastolic function in patients with hypertensive left ventricular hypertrophy.Circulation, 1994
- Angiotensin as Local Modulating Factor in Ventricular Dysfunction and Failure Due to Coronary Artery DiseaseDrugs, 1994
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial)The American Journal of Cardiology, 1990
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984